Openedges Technology, Inc. Logo

Openedges Technology, Inc.

Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.

394280 | KO

Overview

Corporate Details

ISIN(s):
KR7394280002
LEI:
Country:
South Korea
Address:
서울특별시 강남구 역삼로 114 현죽빌딩 13층, 서울특별시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Openedges Technology, Inc. is a semiconductor intellectual property (IP) provider specializing in integrated solutions for artificial intelligence and high-performance computing. The company positions itself as a leading provider of a total memory subsystem and AI platform IP. Its product portfolio includes a range of solutions such as DDR memory controllers, DDR PHY, Network-on-Chip (NoC) interconnects, and Neural Processing Unit (NPU) IPs. These components are designed to enable efficient data processing for applications in AI, smart computing, and the Internet of Things (IoT). Founded in 2017, Openedges supplies essential modules for semiconductor companies developing advanced systems-on-chip (SoCs).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 29.3 KB
2025-09-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-07-31 00:00
Share Issue/Capital Change
전환주식의전환가액조정
Korean 12.2 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 200.6 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 133.0 KB
2025-07-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 157.9 KB
2025-07-14 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 10.4 KB
2025-07-01 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 27.2 KB
2025-06-27 00:00
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
Korean 10.0 KB
2025-06-17 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 14.3 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 972.4 KB
2025-05-15 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Openedges Technology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Openedges Technology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Openedges Technology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus
CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea
030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan
4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan
7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.